Format
Sort by
Items per page

Send to

Choose Destination

Best matches for s100b schizophrenia:

S100B and schizophrenia. Yelmo-Cruz S et al. Psychiatry Clin Neurosci. (2013)

Systematic review and meta-analysis of circulating S100B blood levels in schizophrenia. Aleksovska K et al. PLoS One. (2014)

Levels of S100B are raised in female patients with schizophrenia. O'Connell K et al. BMC Psychiatry. (2013)

Search results

Items: 1 to 20 of 76

1.

Adjunctive Use of a Standardized Extract of Withania somnifera (Ashwagandha) to Treat Symptom Exacerbation in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study.

Chengappa KNR, Brar JS, Gannon JM, Schlicht PJ.

J Clin Psychiatry. 2018 Jul 10;79(5). pii: 17m11826. doi: 10.4088/JCP.17m11826.

2.

Gunn rats with glial activation in the hippocampus show prolonged immobility time in the forced swimming test and tail suspension test.

Arauchi R, Hashioka S, Tsuchie K, Miyaoka T, Tsumori T, Limoa E, Azis IA, Oh-Nishi A, Miura S, Otsuki K, Kanayama M, Izuhara M, Nagahama M, Kawano K, Araki T, Liaury K, Abdullah RA, Wake R, Hayashida M, Inoue K, Horiguchi J.

Brain Behav. 2018 Jun 28:e01028. doi: 10.1002/brb3.1028. [Epub ahead of print]

3.

A longitudinal study of alterations of S100b, sRAGE and Fas Ligand in association to olanzapine medication in a sample of first episode patients with schizophrenia.

Gerasimou C, Tsoporis JN, Siafakas N, Hatziagelaki E, Kallergi M, Chatziioannou SN, Parker TG, Parissis J, Salpeas V, Papageorgiou C, Rizos E.

CNS Neurol Disord Drug Targets. 2018 Jun 5. doi: 10.2174/1871527317666180605120244. [Epub ahead of print]

PMID:
29875007
4.

Genetic Variants Within Molecular Targets of Antipsychotic Treatment: Effects on Treatment Response, Schizophrenia Risk, and Psychopathological Features.

Calabrò M, Porcelli S, Crisafulli C, Wang SM, Lee SJ, Han C, Patkar AA, Masand PS, Albani D, Raimondi I, Forloni G, Bin S, Cristalli C, Mantovani V, Pae CU, Serretti A.

J Mol Neurosci. 2018 Jan;64(1):62-74. doi: 10.1007/s12031-017-1002-1. Epub 2017 Nov 21.

PMID:
29164477
5.

Cognitive deficit in patients with paranoid schizophrenia: Its clinical and laboratory correlates.

Dorofeikova M, Neznanov N, Petrova N.

Psychiatry Res. 2018 Apr;262:542-548. doi: 10.1016/j.psychres.2017.09.041. Epub 2017 Sep 20.

PMID:
28951142
6.

Elevated Plasma S100B, Psychotic Symptoms, and Cognition in Schizophrenia.

Deng H, Kahlon RS, Mohite S, Amin PA, Zunta-Soares G, Colpo GD, Stertz L, Fries GR, Walss-Bass C, Soares JC, Okusaga OO.

Psychiatr Q. 2018 Mar;89(1):53-60. doi: 10.1007/s11126-017-9514-y.

PMID:
28435992
7.

Day/night changes in serum S100B protein concentrations in acute paranoid schizophrenia.

Morera-Fumero AL, Díaz-Mesa E, Abreu-Gonzalez P, Fernandez-Lopez L, Cejas-Mendez MDR.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Apr 3;75:207-212. doi: 10.1016/j.pnpbp.2017.02.007. Epub 2017 Feb 8.

8.

Cognitive dysfunction correlates with elevated serum S100B concentration in drug-free acutely relapsed patients with schizophrenia.

Chen S, Tian L, Chen N, Xiu M, Wang Z, Yang G, Wang C, Yang F, Tan Y.

Psychiatry Res. 2017 Jan;247:6-11. doi: 10.1016/j.psychres.2016.09.029. Epub 2016 Sep 22.

PMID:
27863321
9.

Negative Correlation between Serum S100B and Leptin Levels in Schizophrenic Patients During Treatment with Clozapine and Risperidone: Preliminary Evidence.

Hendouei N, Hosseini SH, Panahi A, Khazaeipour Z, Barari F, Sahebnasagh A, Ala S.

Iran J Pharm Res. 2016 Winter;15(1):323-30.

10.

Higher Plasma S100B Concentrations in Schizophrenia Patients, and Dependently Associated with Inflammatory Markers.

Hong W, Zhao M, Li H, Peng F, Wang F, Li N, Xiang H, Su Y, Huang Y, Zhang S, Zhao G, Zhou R, Mao L, Lin Z, Fang Y, Zhang Q, Xie B.

Sci Rep. 2016 Jun 9;6:27584. doi: 10.1038/srep27584.

11.

Effects of enriched environment on alterations in the prefrontal cortex GFAP- and S100B-immunopositive astrocytes and behavioral deficits in MK-801-treated rats.

Rahati M, Nozari M, Eslami H, Shabani M, Basiri M.

Neuroscience. 2016 Jun 21;326:105-116. doi: 10.1016/j.neuroscience.2016.03.065. Epub 2016 Apr 5.

PMID:
27063100
12.

Identifying S100B as a Biomarker and a Therapeutic Target For Brain Injury and Multiple Diseases.

Chong ZZ, Changyaleket B, Xu H, Dull RO, Schwartz DE.

Curr Med Chem. 2016;23(15):1571-96. Review.

PMID:
27048377
13.

Serum S100B Protein is Specifically Related to White Matter Changes in Schizophrenia.

Milleit B, Smesny S, Rothermundt M, Preul C, Schroeter ML, von Eiff C, Ponath G, Milleit C, Sauer H, Gaser C.

Front Cell Neurosci. 2016 Mar 8;10:33. doi: 10.3389/fncel.2016.00033. eCollection 2016.

14.

Serum S100B Is Related to Illness Duration and Clinical Symptoms in Schizophrenia-A Meta-Regression Analysis.

Schümberg K, Polyakova M, Steiner J, Schroeter ML.

Front Cell Neurosci. 2016 Feb 25;10:46. doi: 10.3389/fncel.2016.00046. eCollection 2016.

15.

Changes in Astroglial Markers in a Maternal Immune Activation Model of Schizophrenia in Wistar Rats are Dependent on Sex.

de Souza DF, Wartchow KM, Lunardi PS, Brolese G, Tortorelli LS, Batassini C, Biasibetti R, Gonçalves CA.

Front Cell Neurosci. 2015 Dec 24;9:489. doi: 10.3389/fncel.2015.00489. eCollection 2015.

16.

Biomarkers of psychiatric diseases: current status and future prospects.

Kalia M, Costa E Silva J.

Metabolism. 2015 Mar;64(3 Suppl 1):S11-5. doi: 10.1016/j.metabol.2014.10.026. Epub 2014 Oct 30. Review.

PMID:
25467847
17.

The importance of glia in dealing with stress.

Woodbury-Fariña MA.

Psychiatr Clin North Am. 2014 Dec;37(4):679-705. doi: 10.1016/j.psc.2014.08.003. Epub 2014 Nov 25. Review.

PMID:
25455071
18.

Systematic review and meta-analysis of circulating S100B blood levels in schizophrenia.

Aleksovska K, Leoncini E, Bonassi S, Cesario A, Boccia S, Frustaci A.

PLoS One. 2014 Sep 9;9(9):e106342. doi: 10.1371/journal.pone.0106342. eCollection 2014. Review.

19.

Pro-inflammatory cytokine levels are raised in female schizophrenia patients treated with clozapine.

O'Connell KE, Thakore J, Dev KK.

Schizophr Res. 2014 Jun;156(1):1-8. doi: 10.1016/j.schres.2014.03.020. Epub 2014 Apr 16.

PMID:
24742875
20.

S100B is downregulated in the nuclear proteome of schizophrenia corpus callosum.

Steiner J, Schmitt A, Schroeter ML, Bogerts B, Falkai P, Turck CW, Martins-de-Souza D.

Eur Arch Psychiatry Clin Neurosci. 2014 Jun;264(4):311-6. doi: 10.1007/s00406-014-0490-z. Epub 2014 Feb 7.

PMID:
24504531

Supplemental Content

Loading ...
Support Center